Hyperfine (HYPR) Non-Current Deffered Revenue (2021 - 2026)
Hyperfine posted quarterly Non-Current Deffered Revenue of $713000.0 for Q1 2026, down 30.64% year-on-year from $1.0 million in Q1 2025, and down 2.19% on a QoQ basis from $729000.0 in Q4 2025.
Hyperfine (HYPR) has 6 years of Non-Current Deffered Revenue data on file, last reported at $713000.0 in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Deffered Revenue fell 30.64% year-over-year to $713000.0; the trailing twelve-month figure through Mar 2026 stood at $713000.0 (down 30.64% YoY), and the FY2025 full-year result was $729000.0, down 30.83% from the prior year.
- Non-Current Deffered Revenue for Q1 2026 stood at $713000.0, down from $729000.0 in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $1.5 million in Q4 2022 and bottomed at $713000.0 in Q1 2026.
- The 5-year median for Non-Current Deffered Revenue is $1.0 million (2024), against an average of $1.0 million.
- Peak annual rise in Non-Current Deffered Revenue reached 199.22% in 2022, while the deepest fall reached 89.72% in 2022.
- A 5-year view of Non-Current Deffered Revenue shows it stood at $1.5 million in 2022, then sank by 36.57% to $968000.0 in 2023, then grew by 8.88% to $1.1 million in 2024, then slumped by 30.83% to $729000.0 in 2025, then decreased by 2.19% to $713000.0 in 2026.
- The last three Non-Current Deffered Revenue figures came in at $713000.0 (Q1 2026), $729000.0 (Q4 2025), and $974000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 512.79 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Hyperfine | 149.47 Mn | 108.20 Mn | 1.98 Mn | 713,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 713,000.00 |
| Dec 31, 2025 | 729,000.00 |
| Sep 30, 2025 | 974,000.00 |
| Jun 30, 2025 | 914,000.00 |
| Mar 31, 2025 | 1.03 Mn |
| Dec 31, 2024 | 1.05 Mn |
| Sep 30, 2024 | 1.11 Mn |
| Jun 30, 2024 | 1.06 Mn |
| Mar 31, 2024 | 1.02 Mn |
| Dec 31, 2023 | 968,000.00 |
| Sep 30, 2023 | 1.09 Mn |
| Jun 30, 2023 | 1.28 Mn |
| Mar 31, 2023 | 1.36 Mn |
| Dec 31, 2022 | 1.53 Mn |
| Sep 30, 2022 | 889,000.00 |
| Jun 30, 2022 | 745,000.00 |
| Mar 31, 2022 | 851,000.00 |
| Dec 31, 2021 | 510,000.00 |
| Sep 30, 2021 | 7.25 Mn |
| Jun 30, 2021 | 7.25 Mn |
| Mar 31, 2021 | 7.25 Mn |